{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T09:39:58Z","timestamp":1769506798961,"version":"3.49.0"},"reference-count":140,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.abb.2024.109994","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T09:28:15Z","timestamp":1713259695000},"page":"109994","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Current knowledge on therapeutic, diagnostic, and prognostics applications of exosomes in multiple myeloma: Opportunities and challenges"],"prefix":"10.1016","volume":"756","author":[{"given":"Aghdas","family":"Ramezani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aida","family":"Tafazoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Salimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahlegha","family":"Ghavami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanie","family":"Arjmandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahman","family":"Khalesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra Sadat","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0493-9595","authenticated-orcid":false,"given":"Saeed","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.abb.2024.109994_bib1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bbcan.2012.03.006","article-title":"Tumor cell-derived exosomes: a message in a bottle","volume":"1826","author":"Kharaziha","year":"2012","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.abb.2024.109994_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jconrel.2016.02.037","article-title":"Exosomes as therapeutics: the implications of molecular composition and exosomal heterogeneity","volume":"228","author":"Ferguson","year":"2016","journal-title":"J. Contr. Release"},{"issue":"7","key":"10.1016\/j.abb.2024.109994_bib3","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.3390\/cancers13071635","article-title":"Recent progress of exosomes in multiple myeloma: pathogenesis, diagnosis, prognosis and therapeutic strategies","volume":"13","author":"Wang","year":"2021","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.abb.2024.109994_bib4","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1038\/s41375-020-01041-z","article-title":"Extracellular microvesicles\/exosomes: discovery, disbelief, acceptance, and the future?","volume":"34","author":"Ratajczak","year":"2020","journal-title":"Leukemia"},{"issue":"1\u20132","key":"10.1016\/j.abb.2024.109994_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/21541248.2016.1264352","article-title":"New insights into the function of Rab GTPases in the context of exosomal secretion","volume":"9","author":"Blanc","year":"2018","journal-title":"Small GTPases"},{"issue":"8","key":"10.1016\/j.abb.2024.109994_bib6","doi-asserted-by":"crossref","first-page":"R397","DOI":"10.1016\/j.cub.2018.01.005","article-title":"SNARE complex assembly and disassembly","volume":"28","author":"Yoon","year":"2018","journal-title":"Curr. Biol."},{"issue":"1","key":"10.1016\/j.abb.2024.109994_bib7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.7150\/ijbs.53671","article-title":"Regulation of exosome production and cargo sorting","volume":"17","author":"Wei","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"5","key":"10.1016\/j.abb.2024.109994_bib8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/tra.12558","article-title":"The biology of extracellular microvesicles","volume":"19","author":"Sedgwick","year":"2018","journal-title":"Traffic"},{"issue":"3","key":"10.1016\/j.abb.2024.109994_bib9","doi-asserted-by":"crossref","first-page":"789","DOI":"10.7150\/thno.18133","article-title":"Progress in exosome isolation techniques","volume":"7","author":"Li","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.abb.2024.109994_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11010-020-03703-z","article-title":"Inside (sight) of tiny communicator: exosome biogenesis, secretion, and uptake","volume":"467","author":"Jadli","year":"2020","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.abb.2024.109994_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13578-019-0282-2","article-title":"Exosomes: biogenesis, biologic function and clinical potential","volume":"9","author":"Zhang","year":"2019","journal-title":"Cell Biosci."},{"key":"10.1016\/j.abb.2024.109994_bib12","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1146\/annurev-biochem-013118-111902","article-title":"Exosomes","volume":"88","author":"Pegtel","year":"2019","journal-title":"Annu. Rev. Biochem."},{"issue":"2","key":"10.1016\/j.abb.2024.109994_bib13","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.imlet.2006.09.005","article-title":"Exosomes: from biogenesis and secretion to biological function","volume":"107","author":"Keller","year":"2006","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.abb.2024.109994_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-019-0991-5","article-title":"Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance","volume":"18","author":"Mashouri","year":"2019","journal-title":"Mol. Cancer"},{"issue":"24","key":"10.1016\/j.abb.2024.109994_bib15","first-page":"5553","article-title":"Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles","volume":"126","author":"Colombo","year":"2013","journal-title":"J. Cell Sci."},{"issue":"5","key":"10.1016\/j.abb.2024.109994_bib16","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3390\/membranes12050498","article-title":"Current knowledge on exosome biogenesis, cargo-sorting mechanism and therapeutic implications","volume":"12","author":"Xie","year":"2022","journal-title":"Membranes"},{"issue":"2","key":"10.1016\/j.abb.2024.109994_bib17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41422-020-00418-0","article-title":"An exosome pathway without an ESCRT","volume":"31","author":"Kenific","year":"2021","journal-title":"Cell Res."},{"issue":"7","key":"10.1016\/j.abb.2024.109994_bib18","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/tra.12803","article-title":"The role of lipids in exosome biology and intercellular communication: function, analytics and applications","volume":"22","author":"Donoso\u2010Quezada","year":"2021","journal-title":"Traffic"},{"key":"10.1016\/j.abb.2024.109994_bib19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1134\/S0006297920020054","article-title":"Lipid rafts in exosome biogenesis","volume":"85","author":"Skryabin","year":"2020","journal-title":"Biochemistry (Moscow)"},{"key":"10.1016\/j.abb.2024.109994_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1192866","article-title":"Exosomes, miRNAs, and lncRNAs in breast cancer: therapeutic and diagnostic applications","volume":"14","author":"Hashemi","year":"2023","journal-title":"Front. Genet."},{"key":"10.1016\/j.abb.2024.109994_bib21","series-title":"Nanopharmaceuticals in Regenerative Medicine","first-page":"67","article-title":"The Emerging role of exosome nanoparticles in regenerative medicine","author":"Hashemi","year":"2022"},{"issue":"7","key":"10.1016\/j.abb.2024.109994_bib22","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3390\/jcm8071027","article-title":"Leptin modulates exosome biogenesis in breast cancer cells: an additional mechanism in cell-to-cell communication","volume":"8","author":"Giordano","year":"2019","journal-title":"J. Clin. Med."},{"issue":"8","key":"10.1016\/j.abb.2024.109994_bib23","first-page":"1950","article-title":"Molecular detection of micrometastases and circulating tumor cells in solid tumors","volume":"5","author":"Ghossein","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.abb.2024.109994_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.686551","article-title":"An examination of the putative role of melatonin in exosome biogenesis","volume":"9","author":"Amini","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.abb.2024.109994_bib25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/biomedicines6030079","article-title":"Pathogens and their effect on exosome biogenesis and composition","volume":"6","author":"Jones","year":"2018","journal-title":"Biomedicines"},{"key":"10.1016\/j.abb.2024.109994_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.canlet.2020.03.017","article-title":"Hypoxia in tumor microenvironment regulates exosome biogenesis: molecular mechanisms and translational opportunities","volume":"479","author":"Kumar","year":"2020","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.abb.2024.109994_bib27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.arcmed.2020.10.007","article-title":"Metformin increases exosome biogenesis and secretion in U87 MG human glioblastoma cells: a possible mechanism of therapeutic resistance","volume":"52","author":"Soraya","year":"2021","journal-title":"Arch. Med. Res."},{"issue":"2","key":"10.1016\/j.abb.2024.109994_bib28","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/biom13020222","article-title":"Effect of ethanol on exosome biogenesis: possible mechanisms and therapeutic implications","volume":"13","author":"Sundar","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.abb.2024.109994_bib29","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4649705","article-title":"Potential role of exosomes in cancer metastasis","volume":"2019","author":"Tian","year":"2019","journal-title":"BioMed Res. Int."},{"issue":"8","key":"10.1016\/j.abb.2024.109994_bib30","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1111\/cas.13697","article-title":"Exosomes in cancer development and clinical applications","volume":"109","author":"Tai","year":"2018","journal-title":"Cancer Sci."},{"issue":"7","key":"10.1016\/j.abb.2024.109994_bib31","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1021\/acsabm.3c00199","article-title":"Clinical impact of exosomes in colorectal cancer metastasis","volume":"6","author":"Ghosh","year":"2023","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.abb.2024.109994_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5772\/61186","article-title":"Exosomes: mechanisms of uptake","volume":"4","author":"McKelvey","year":"2015","journal-title":"Journal of circulating biomarkers"},{"issue":"1","key":"10.1016\/j.abb.2024.109994_bib33","doi-asserted-by":"crossref","first-page":"3.22. 1","DOI":"10.1002\/0471143030.cb0322s30","article-title":"Isolation and characterization of exosomes from cell culture supernatants and biological fluids","volume":"30","author":"Th\u00e9ry","year":"2006","journal-title":"Curr. Protoc. Cell Biol."},{"issue":"2","key":"10.1016\/j.abb.2024.109994_bib34","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/genes4020152","article-title":"Signaling pathways in exosomes biogenesis, secretion and fate","volume":"4","author":"Urbanelli","year":"2013","journal-title":"Genes"},{"key":"10.1016\/j.abb.2024.109994_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.811971","article-title":"Review on strategies and technologies for exosome isolation and purification","volume":"9","author":"Chen","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"18","key":"10.1016\/j.abb.2024.109994_bib36","doi-asserted-by":"crossref","first-page":"6466","DOI":"10.3390\/ijms21186466","article-title":"A review of exosomal isolation methods: is size exclusion chromatography the best option?","volume":"21","author":"Sidhom","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.abb.2024.109994_bib37","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.3390\/ijms22042158","article-title":"Human placenta exosomes: biogenesis, isolation, composition, and prospects for use in diagnostics","volume":"22","author":"Burkova","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.abb.2024.109994_bib38","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","article-title":"Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles","volume":"30","author":"Colombo","year":"2014","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"19","key":"10.1016\/j.abb.2024.109994_bib39","doi-asserted-by":"crossref","first-page":"6631","DOI":"10.1039\/C5AN00688K","article-title":"Exosomes: improved methods to characterize their morphology, RNA content, and surface protein biomarkers","volume":"140","author":"Wu","year":"2015","journal-title":"Analyst"},{"issue":"3","key":"10.1016\/j.abb.2024.109994_bib40","doi-asserted-by":"crossref","DOI":"10.1088\/2632-959X\/aceb7d","article-title":"Isolation and substrate dependence on extracellular vesicle characterisation using atomic force microscopy","volume":"4","author":"Dobhal","year":"2023","journal-title":"Nano Express"},{"key":"10.1016\/j.abb.2024.109994_bib41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-4939-6728-5_2","article-title":"Tunable resistive pulse sensing for the characterization of extracellular vesicles","author":"Maas","year":"2017","journal-title":"Exosomes Microvesicles: Methods and protocols"},{"issue":"1","key":"10.1016\/j.abb.2024.109994_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227949","article-title":"Cryo-electron microscopy of extracellular vesicles from cerebrospinal fluid","volume":"15","author":"Emelyanov","year":"2020","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.abb.2024.109994_bib43","doi-asserted-by":"crossref","first-page":"10499","DOI":"10.1021\/acsnano.9b04480","article-title":"Mapping subpopulations of cancer cell-derived extracellular vesicles and particles by nano-flow cytometry","volume":"13","author":"Choi","year":"2019","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.abb.2024.109994_bib44","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2019.1697028","article-title":"Quality and efficiency assessment of six extracellular vesicle isolation methods by nano-flow cytometry","volume":"9","author":"Tian","year":"2020","journal-title":"J. Extracell. Vesicles"},{"issue":"4","key":"10.1016\/j.abb.2024.109994_bib45","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/MOH.0000000000000259","article-title":"Cell autonomous and microenvironmental regulation of tumor progression in precursor states of multiple myeloma","volume":"23","author":"Manier","year":"2016","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.abb.2024.109994_bib46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/B978-0-12-386469-7.00002-5","article-title":"The microenvironment and molecular biology of the multiple myeloma tumor","volume":"110","author":"Lemaire","year":"2011","journal-title":"Adv. Cancer Res."},{"issue":"4","key":"10.1016\/j.abb.2024.109994_bib47","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1172\/JCI66517","article-title":"BM mesenchymal stromal cell\u2013derived exosomes facilitate multiple myeloma progression","volume":"123","author":"Roccaro","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.abb.2024.109994_bib48","first-page":"555","article-title":"Bone marrow stromal cell\u2013derived exosomes as communicators in drug resistance in multiple myeloma cells","volume":"124","author":"Wang","year":"2014","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"6","key":"10.1016\/j.abb.2024.109994_bib49","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1158\/1078-0432.CCR-18-2363","article-title":"Exosome-transmitted PSMA3 and PSMA3-AS1 promote proteasome inhibitor resistance in multiple myeloma","volume":"25","author":"Xu","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.abb.2024.109994_bib50","first-page":"1","article-title":"Additive effect of metastamiR-193b and breast cancer metastasis suppressor 1 as an anti-metastatic strategy","author":"Hashemi","year":"2018","journal-title":"Breast Cancer"},{"issue":"10","key":"10.1016\/j.abb.2024.109994_bib51","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1182\/blood-2005-04-1438","article-title":"Induction of HM1. 24 peptide\u2013specific cytotoxic T lymphocytes by using peripheral-blood stem-cell harvests in patients with multiple myeloma","volume":"106","author":"Jalili","year":"2005","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.abb.2024.109994_bib52","doi-asserted-by":"crossref","first-page":"8808","DOI":"10.1158\/1078-0432.CCR-05-1553","article-title":"Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96","volume":"11","author":"Qian","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.abb.2024.109994_bib53","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.3390\/cancers13092018","article-title":"Overcoming the immunosuppressive tumor microenvironment in multiple myeloma","volume":"13","author":"Uckun","year":"2021","journal-title":"Cancers"},{"issue":"24","key":"10.1016\/j.abb.2024.109994_bib54","first-page":"2731","article-title":"Cancer immunoediting and immune dysregulation in multiple myeloma","volume":"136","author":"Nakamura","year":"2020","journal-title":"Blood, The Journal of the American Society of Hematology"},{"key":"10.1016\/j.abb.2024.109994_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.608815","article-title":"Exosomes in the pathogenesis and treatment of multiple myeloma in the context of the bone marrow microenvironment","volume":"10","author":"Chen","year":"2020","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.abb.2024.109994_bib56","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/jcm7030055","article-title":"A challenge to aging society by microRNA in extracellular vesicles: MicroRNA in extracellular vesicles as promising biomarkers and novel therapeutic targets in multiple myeloma","volume":"7","author":"Yamamoto","year":"2018","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.abb.2024.109994_bib57","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5396628","article-title":"Bioactivity of exosomes derived from trained natural killer cells versus non-trained one: more functional and antitumor activity","volume":"2022","author":"Mohammadi","year":"2022","journal-title":"BioMed Res. Int."},{"issue":"1","key":"10.1016\/j.abb.2024.109994_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-023-02996-6","article-title":"Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art","volume":"23","author":"Hatami","year":"2023","journal-title":"Cancer Cell Int."},{"issue":"11","key":"10.1016\/j.abb.2024.109994_bib59","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1073\/pnas.0911929107","article-title":"Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease","volume":"107","author":"Vallet","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"21","key":"10.1016\/j.abb.2024.109994_bib60","doi-asserted-by":"crossref","first-page":"8329","DOI":"10.1158\/0008-5472.CAN-10-2179","article-title":"Heparanase enhances local and systemic osteolysis in multiple myeloma by upregulating the expression and secretion of RANKL","volume":"70","author":"Yang","year":"2010","journal-title":"Cancer Res."},{"issue":"15","key":"10.1016\/j.abb.2024.109994_bib61","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.2217\/bmm-2019-0060","article-title":"Serum DKK1 is correlated with \u03b3 peak of serum electrophoresis in multiple myeloma: a multicenter biomarker study","volume":"13","author":"Hashemi","year":"2019","journal-title":"Biomarkers Med."},{"key":"10.1016\/j.abb.2024.109994_bib62","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1575468","article-title":"Potential relationship between clinical significance and serum exosomal miRNAs in patients with multiple myeloma","volume":"2019","author":"Zhang","year":"2019","journal-title":"BioMed Res. Int."},{"issue":"21","key":"10.1016\/j.abb.2024.109994_bib63","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.9021","article-title":"Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.abb.2024.109994_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13578-020-00515-y","article-title":"Potential roles and prognostic significance of exosomes in cancer drug resistance","volume":"11","author":"Mostafazadeh","year":"2021","journal-title":"Cell Biosci."},{"key":"10.1016\/j.abb.2024.109994_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-017-0730-8","article-title":"Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes","volume":"16","author":"Iaccino","year":"2017","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.abb.2024.109994_bib66","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrclinonc.2017.14","article-title":"Integrating liquid biopsies into the management of cancer","volume":"14","author":"Siravegna","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.abb.2024.109994_bib67","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41408-018-0139-7","article-title":"Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts","volume":"8","author":"Faict","year":"2018","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.abb.2024.109994_bib68","article-title":"Bone marrow microenvironment in multiple myeloma progression","volume":"2012","author":"Manier","year":"2012","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.abb.2024.109994_bib69","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.1007\/s13277-015-3741-3","article-title":"High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders","volume":"36","author":"Caivano","year":"2015","journal-title":"Tumor Biol."},{"issue":"20","key":"10.1016\/j.abb.2024.109994_bib70","first-page":"3013","article-title":"Characterization of multiple myeloma vesicles by label\u2010free relative quantitation","volume":"13","author":"Harshman","year":"2013","journal-title":"Proteomics"},{"key":"10.1016\/j.abb.2024.109994_bib71","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bios.2015.09.061","article-title":"Merging colloidal nanoplasmonics and surface plasmon resonance spectroscopy for enhanced profiling of multiple myeloma-derived exosomes","volume":"77","author":"Di","year":"2016","journal-title":"Biosens. Bioelectron."},{"issue":"17","key":"10.1016\/j.abb.2024.109994_bib72","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.3390\/cancers14174136","article-title":"Circulating tumour cells, cell free DNA and tumour-educated platelets as reliable prognostic and management biomarkers for the liquid biopsy in multiple myeloma","volume":"14","author":"Allegra","year":"2022","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.abb.2024.109994_bib73","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/hon.2554","article-title":"Circulating exosomal long noncoding RNA PRINS\u2014first findings in monoclonal gammopathies","volume":"36","author":"Sedlarikova","year":"2018","journal-title":"Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.abb.2024.109994_bib74","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3233\/CBM-160158","article-title":"Upregulated lncRNA-PCAT1 is closely related to clinical diagnosis of multiple myeloma as a predictive biomarker in serum","volume":"18","author":"Shen","year":"2017","journal-title":"Cancer Biomarkers"},{"issue":"12","key":"10.1016\/j.abb.2024.109994_bib75","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1042\/BCJ20170962","article-title":"DIS3 isoforms vary in their endoribonuclease activity and are differentially expressed within haematological cancers","volume":"475","author":"Robinson","year":"2018","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.abb.2024.109994_bib76","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ccell.2014.09.005","article-title":"Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis","volume":"26","author":"Melo","year":"2014","journal-title":"Cancer Cell"},{"issue":"24","key":"10.1016\/j.abb.2024.109994_bib77","doi-asserted-by":"crossref","first-page":"6154","DOI":"10.7150\/jca.31752","article-title":"Potential therapeutic roles of exosomes in multiple myeloma: a systematic review","volume":"10","author":"Li","year":"2019","journal-title":"J. Cancer"},{"issue":"15","key":"10.1016\/j.abb.2024.109994_bib78","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.7319","article-title":"Serum high expression of miR-214 and miR-135b as novel predictor for myeloma bone disease development and prognosis","volume":"7","author":"Hao","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.abb.2024.109994_bib79","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1515\/cclm-2015-1108","article-title":"Identification of a novel microRNA, miR-4449, as a potential blood based marker in multiple myeloma","volume":"55","author":"Shen","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"issue":"12","key":"10.1016\/j.abb.2024.109994_bib80","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1038\/bjc.2012.525","article-title":"Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma","volume":"107","author":"Jones","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.abb.2024.109994_bib81","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s13402-016-0300-x","article-title":"MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies-a short report","volume":"40","author":"Caivano","year":"2017","journal-title":"Cell. Oncol."},{"issue":"3","key":"10.1016\/j.abb.2024.109994_bib82","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3324\/haematol.2013.093500","article-title":"Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance","volume":"99","author":"Kubiczkova","year":"2014","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.abb.2024.109994_bib83","article-title":"Microvesicles released from multiple myeloma cells are equipped with ectoenzymes belonging to canonical and non-canonical adenosinergic pathways and produce adenosine from ATP and NAD+","volume":"7","author":"Morandi","year":"2018","journal-title":"OncoImmunology"},{"key":"10.1016\/j.abb.2024.109994_bib84","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.3389\/fimmu.2021.816231","article-title":"Extracellular vesicles as biomarkers of acute graft-vs.-host disease after haploidentical stem cell transplantation and post-transplant cyclophosphamide","volume":"12","author":"Lia","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.abb.2024.109994_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-015-0323-3","article-title":"Targeting of YAP1 by microRNA-15a and microRNA-16-1 exerts tumor suppressor function in gastric adenocarcinoma","volume":"14","author":"Kang","year":"2015","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.abb.2024.109994_bib86","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.3390","article-title":"Lung tumorigenesis induced by human vascular endothelial growth factor (hVEGF)-A165 overexpression in transgenic mice and amelioration of tumor formation by miR-16","volume":"6","author":"Tung","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.abb.2024.109994_bib87","first-page":"1287","article-title":"Downregulation of miRNA-15a and miRNA-16 promote tumor proliferation in multiple myeloma by increasing CABIN1 expression","volume":"15","author":"Zhang","year":"2018","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.abb.2024.109994_bib88","first-page":"332","article-title":"Expression level of microRNA-92a and its clinical significance in multiple myeloma patients","volume":"34","author":"Qu","year":"2013","journal-title":"Zhonghua xue ye xue za zhi= Zhonghua Xueyexue Zazhi"},{"issue":"11","key":"10.1016\/j.abb.2024.109994_bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41408-018-0139-7","article-title":"Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts","volume":"8","author":"Faict","year":"2018","journal-title":"Blood Cancer J."},{"issue":"6","key":"10.1016\/j.abb.2024.109994_bib90","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1158\/1078-0432.CCR-10-2476","article-title":"SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase\/syndecan-1 axis","volume":"17","author":"Ritchie","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.abb.2024.109994_bib91","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1074\/jbc.M115.686295","article-title":"Fibronectin on the surface of myeloma cell-derived exosomes mediates exosome-cell interactions","volume":"291","author":"Purushothaman","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.abb.2024.109994_bib92","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.18632\/oncotarget.6408","article-title":"Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma","volume":"7","author":"Ramani","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.abb.2024.109994_bib93","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.matbio.2017.09.001","article-title":"Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior","volume":"65","author":"Bandari","year":"2018","journal-title":"Matrix Biol."},{"issue":"3","key":"10.1016\/j.abb.2024.109994_bib94","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1279372","article-title":"Genotoxic stress modulates the release of exosomes from multiple myeloma cells capable of activating NK cell cytokine production: role of HSP70\/TLR2\/NF-kB axis","volume":"6","author":"Vulpis","year":"2017","journal-title":"OncoImmunology"},{"issue":"41","key":"10.1016\/j.abb.2024.109994_bib95","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.1038\/s41388-018-0359-0","article-title":"Exosome-mediated transfer of lncRUNX2-AS1 from multiple myeloma cells to MSCs contributes to osteogenesis","volume":"37","author":"Li","year":"2018","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.abb.2024.109994_bib96","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1158\/2326-6066.CIR-17-0604","article-title":"Drug-induced senescent multiple myeloma cells elicit NK cell proliferation by direct or exosome-mediated IL15 trans-PresentationSenescent MM promotes IL15-mediated NK cell proliferation","volume":"6","author":"Borrelli","year":"2018","journal-title":"Cancer Immunol. Res."},{"issue":"4","key":"10.1016\/j.abb.2024.109994_bib97","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/aps.2017.118","article-title":"The ceramide pathway is involved in the survival, apoptosis and exosome functions of human multiple myeloma cells in vitro","volume":"39","author":"Cheng","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.abb.2024.109994_bib98","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.7150\/thno.47996","article-title":"Endocytic pathway inhibition attenuates extracellular vesicle-induced reduction of chemosensitivity to bortezomib in multiple myeloma cells","volume":"11","author":"Tu","year":"2021","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.abb.2024.109994_bib99","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2217\/nnm-2022-0237","article-title":"Novel delivery of sorafenib by natural killer cell-derived exosomes-enhanced apoptosis in triple-negative breast cancer","volume":"18","author":"Hashemi","year":"2023","journal-title":"Nanomedicine"},{"issue":"6","key":"10.1016\/j.abb.2024.109994_bib100","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.nano.2016.03.002","article-title":"Disposition and safety of inhaled biodegradable nanomedicines: opportunities and challenges","volume":"12","author":"Haque","year":"2016","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.abb.2024.109994_bib101","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.abb.2024.109994_bib102","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.colsurfb.2015.07.013","article-title":"Strategies of polymeric nanoparticles for enhanced internalization in cancer therapy","volume":"135","author":"Sun","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"16","key":"10.1016\/j.abb.2024.109994_bib103","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1038\/s41388-017-0116-9","article-title":"Employing mesenchymal stem cells to support tumor-targeted delivery of extracellular vesicle (EV)-encapsulated microRNA-379","volume":"37","author":"O\u2019brien","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.abb.2024.109994_bib104","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jconrel.2014.07.042","article-title":"Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery","volume":"192","author":"Pascucci","year":"2014","journal-title":"J. Contr. Release"},{"issue":"8","key":"10.1016\/j.abb.2024.109994_bib105","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri2567","article-title":"Membrane vesicles as conveyors of immune responses","volume":"9","author":"Th\u00e9ry","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.abb.2024.109994_bib106","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.biomaterials.2013.11.083","article-title":"A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy","volume":"35","author":"Tian","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.abb.2024.109994_bib107","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","article-title":"Exosomes as drug delivery vehicles for Parkinson's disease therapy","volume":"207","author":"Haney","year":"2015","journal-title":"J. Contr. Release"},{"issue":"3","key":"10.1016\/j.abb.2024.109994_bib108","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.nano.2015.10.012","article-title":"Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells","volume":"12","author":"Kim","year":"2016","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.abb.2024.109994_bib109","article-title":"Research progress in membrane fusion-based hybrid exosomes for drug delivery systems","volume":"10","author":"Liu","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.abb.2024.109994_bib110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.biomaterials.2016.06.024","article-title":"RNAi delivery by exosome-mimetic nanovesicles\u2013Implications for targeting c-Myc in cancer","volume":"102","author":"Lunavat","year":"2016","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.abb.2024.109994_bib111","article-title":"Engineering hybrid exosomes by membrane fusion with liposomes","volume":"6","author":"Sato","year":"2016","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.abb.2024.109994_bib112","doi-asserted-by":"crossref","first-page":"7698","DOI":"10.1021\/nn402232g","article-title":"Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors","volume":"7","author":"Jang","year":"2013","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.abb.2024.109994_bib113","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1038\/s41598-018-20505-y","article-title":"Exosome-Mimetic Nanovesicles from Hepatocytes promote hepatocyte proliferation in vitro and liver regeneration in vivo","volume":"8","author":"Wu","year":"2018","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.abb.2024.109994_bib114","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41401-020-0372-z","article-title":"Advanced biomaterials for cancer immunotherapy","volume":"41","author":"Yang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.abb.2024.109994_bib115","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.clim.2015.03.021","article-title":"Exosomes as nanocarriers for immunotherapy of cancer and inflammatory diseases","volume":"160","author":"Tran","year":"2015","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.abb.2024.109994_bib116","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.4049\/jimmunol.1400703","article-title":"Dendritic cell\u2013derived exosomes as immunotherapies in the fight against cancer","volume":"193","author":"Pitt","year":"2014","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.abb.2024.109994_bib117","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nm0598-594","article-title":"Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes","volume":"4","author":"Zitvogel","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.abb.2024.109994_bib118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-3-10","article-title":"Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial","volume":"3","author":"Escudier","year":"2005","journal-title":"J. Transl. Med."},{"issue":"11","key":"10.1016\/j.abb.2024.109994_bib119","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1111\/j.1582-4934.2009.00851.x","article-title":"Membrane\u2010bound HSP70\u2010engineered myeloma cell\u2010derived exosomes stimulate more efficient CD8+ CTL\u2010and NK\u2010mediated antitumour immunity than exosomes released from heat\u2010shocked tumour cells expressing cytoplasmic HSP70","volume":"14","author":"Xie","year":"2010","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.abb.2024.109994_bib120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-3-9","article-title":"A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer","volume":"3","author":"Morse","year":"2005","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.abb.2024.109994_bib121","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jhep.2017.05.019","article-title":"Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models","volume":"67","author":"Lu","year":"2017","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.abb.2024.109994_bib122","first-page":"427","article-title":"Inhibition of breast cancer metastasis by co-transfection of miR-31\/193b-mimics","volume":"21","author":"Hashemi","year":"2018","journal-title":"Iranian journal of basic medical sciences"},{"issue":"1\u20132","key":"10.1016\/j.abb.2024.109994_bib123","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3727\/096504015X14478843952906","article-title":"Knockdown of microRNA-29a changes the expression of heat shock proteins in breast carcinoma MCF-7 cells","volume":"23","author":"Choghaei","year":"2016","journal-title":"Oncol. Res."},{"issue":"2","key":"10.1016\/j.abb.2024.109994_bib124","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/17476348.2017.1279403","article-title":"Lung cancer and miRNAs: a possible remedy for anti-metastatic, therapeutic and diagnostic applications","volume":"11","author":"Hashemi","year":"2017","journal-title":"Expet Rev. Respir. Med."},{"key":"10.1016\/j.abb.2024.109994_bib125","article-title":"microRNA-181 serves as a dual-role regulator in the development of human cancers","author":"Rezaei","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"8","key":"10.1016\/j.abb.2024.109994_bib126","article-title":"Varying miR-193b-3p expression patterns in breast cancer cell lines indicates its potential for cancer management strategies","volume":"11","author":"Hashemi","year":"2018","journal-title":"International Journal of Cancer Management"},{"issue":"10","key":"10.1016\/j.abb.2024.109994_bib127","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/17474086.2018.1517041","article-title":"The potential role of miRNAs in multiple myeloma therapy","volume":"11","author":"Caracciolo","year":"2018","journal-title":"Expet Rev. Hematol."},{"issue":"24","key":"10.1016\/j.abb.2024.109994_bib128","first-page":"8749","article-title":"High heparanase activity in multiple myeloma is associated with elevated microvessel density","volume":"63","author":"Kelly","year":"2003","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.abb.2024.109994_bib129","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/febs.13932","article-title":"Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy","volume":"284","author":"Sanderson","year":"2017","journal-title":"FEBS J."},{"issue":"14","key":"10.1016\/j.abb.2024.109994_bib130","doi-asserted-by":"crossref","first-page":"10093","DOI":"10.1074\/jbc.C112.444562","article-title":"Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes","volume":"288","author":"Thompson","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.abb.2024.109994_bib131","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nrc952","article-title":"Molecular mechanisms of novel therapeutic approaches for multiple myeloma","volume":"2","author":"Hideshima","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.abb.2024.109994_bib132","doi-asserted-by":"crossref","DOI":"10.1111\/ecc.13208","article-title":"Therapeutic potential of antagomiRs in haematological and oncological neoplasms","volume":"29","author":"Innao","year":"2020","journal-title":"Eur. J. Cancer Care"},{"issue":"5","key":"10.1016\/j.abb.2024.109994_bib133","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/14653240903193806","article-title":"Mesenchymal stem cells in hematopoietic stem cell transplantation","volume":"11","author":"Battiwalla","year":"2009","journal-title":"Cytotherapy"},{"key":"10.1016\/j.abb.2024.109994_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2023.100129","article-title":"Exosomes Barcoding: a smart approach for cancer liquid biopsy","volume":"2","author":"Dhar","year":"2023","journal-title":"The Journal of Liquid Biopsy"},{"issue":"8","key":"10.1016\/j.abb.2024.109994_bib135","doi-asserted-by":"crossref","first-page":"11619","DOI":"10.1021\/acsnano.2c04337","article-title":"Future of digital assays to resolve clinical heterogeneity of single extracellular vesicles","volume":"16","author":"Morales","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.abb.2024.109994_bib136","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.saa.2016.01.032","article-title":"A micro-Raman spectroscopic investigation of leukemic U-937 cells in aged cultures","volume":"159","author":"Fazio","year":"2016","journal-title":"Spectrochim. Acta Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.abb.2024.109994_bib137","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.saa.2017.06.020","article-title":"Raman spectroscopy differentiates between sensitive and resistant multiple myeloma cell lines","volume":"187","author":"Franco","year":"2017","journal-title":"Spectrochim. Acta Mol. Biomol. Spectrosc."},{"issue":"3","key":"10.1016\/j.abb.2024.109994_bib138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0218-2","article-title":"Mass spectrometry-based proteome profiling of extracellular vesicles and their roles in cancer biology","volume":"51","author":"Bandu","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.abb.2024.109994_bib139","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/978-1-4939-7231-9_22","article-title":"Isolation of exosomes for the purpose of protein cargo analysis with the use of mass spectrometry","author":"Pietrowska","year":"2017","journal-title":"Functional genomics: methods and protocols"},{"issue":"1","key":"10.1016\/j.abb.2024.109994_bib140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1194\/jlr.R084343","article-title":"Exosomal lipid composition and the role of ether lipids and phosphoinositides in exosome biology","volume":"60","author":"Skotland","year":"2019","journal-title":"J. Lipid Res."}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986124001139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986124001139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T21:11:54Z","timestamp":1715461914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986124001139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":140,"alternative-id":["S0003986124001139"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2024.109994","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current knowledge on therapeutic, diagnostic, and prognostics applications of exosomes in multiple myeloma: Opportunities and challenges","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2024.109994","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109994"}}